Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 1/20 | 0.44 |
| ▸ | THRA | P10827 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | NPC1 | O15118 | 2/20 | 0.42 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | RAB9A | P51151 | 2/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CA7 | P43166 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
| ▸ | NCF1 | P14598 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | NQO1 | P15559 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13347001 | 0.94 | THRA (0.46) | THRASMN1; SMN2MAPK1NCF1KDM4E | |
| SCHEMBL13397870 | 0.89 | LTA4H (0.53) | LTA4HSMN1; SMN2MAPTNPC1HPGD | |
| SCHEMBL29119791 | 0.87 | LTA4H (0.52) | LTA4HSMN1; SMN2MAPTNPC1HPGD | |
| SCHEMBL12411386 | 0.86 | NR1I2 (0.49) | THRASMN1; SMN2MAPK1NCF1KDM4E | |
| SCHEMBL16200805 | 0.84 | LTA4H (0.46) | LTA4HSMN1; SMN2MAPTNPC1HPGD | |
| SCHEMBL4053878 | 0.83 | RARB (0.53) | LTA4HTHRASMN1; SMN2MAPTNPC1 | |
| SCHEMBL16200808 | 0.83 | KDM4E (0.50) | LTA4HSMN1; SMN2MAPTNPC1HPGD | |
| SCHEMBL4061378 | 0.82 | NQO1 (0.57) | LTA4HTHRASMN1; SMN2MAPK1NCF1 | |
| SCHEMBL752943 | 0.81 | ALDH1A1 (0.45) | THRASMN1; SMN2MAPTNCF1KDM4E | |
| SCHEMBL6366925 | 0.81 | THRA (0.49) | LTA4HTHRASMN1; SMN2MAPTMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110195194-A1 | CATIONIC RADIATION CURABLE COMPOSITIONS | AGFA GRAPHICS NV (BE) | 2011-08-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110195194-A1 | CATIONIC RADIATION CURABLE COMPOSITIONS | NR2E3, NR2E1, CCNE2 | LTA4H 2923/4885THRA 1520/4885SMN1; SMN2 3538/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.